{"nct_id":"NCT03769194","title":"Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study.","status":"COMPLETED","status_verified_date":"2022-12","start_date":"2018-12-17","start_date_type":"ACTUAL","primary_completion_date":"2019-12-18","primary_completion_date_type":"ACTUAL","completion_date":"2020-10-02","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}